微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1.71% | -13.64% | -72.68% | 43/70 | 2.21% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | 6.26% | 16.36% | -12.08% | 30/70 | 3.08% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | 7.12% | -5.32% | 138.93% | 23/70 | 3% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | 2.98% | -14.86% | 50.51% | 37/70 | 0.63% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 1.98% | -23.85% | -63.2% | 37/70 | 1.5% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 5.38% | 4.06% | -28.46% | 41/70 | -0.11% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 7.52% | -1.31% | 114.86% | 28/70 | 7.09% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 3.5% | 17.85% | 34.62% | 47/70 | 4.8% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 2.6% | 10.17% | -49.71% | 36/70 | 3.14% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | 5.17% | -14.55% | -32.15% | 42/70 | 6.41% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | 7.62% | -19.37% | 156.57% | 29/70 | 5.07% | 片仔癀 | 23.54% | 行业排名> |
| 2022-06-30 | 2.97% | -32.65% | 25.85% | 45/70 | 3.13% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | 2.36% | -44.86% | -60.99% | 33/70 | 2.15% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | 6.05% | -22.14% | -35.98% | 40/70 | 4.45% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | 9.45% | 14.68% | 114.29% | 23/70 | 7.44% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | 4.41% | -1.56% | 3.04% | 35/70 | 4.61% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 4.28% | 98.15% | -44.92% | 11/70 | 2.67% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | 7.77% | -7.83% | -5.7% | 30/70 | 0.09% | *ST长药 | 7.37% | 行业排名> |
| 2020-09-30 | 8.24% | -9.55% | 83.93% | 28/70 | 6.69% | 沃华医药 | 22.84% | 行业排名> |
| 2020-06-30 | 4.48% | -14.18% | 107.41% | 27/70 | 3.67% | 沃华医药 | 19.47% | 行业排名> |
| 2020-03-31 | 2.16% | -18.8% | -74.38% | 30/70 | 2.09% | 沃华医药 | 12.7% | 行业排名> |
| 2019-12-31 | 8.43% | 24.15% | -7.46% | 34/70 | 5.69% | 济川药业 | 7.33% | 行业排名> |
| 2019-09-30 | 9.11% | 28.13% | 74.52% | 21/70 | 7.19% | 济川药业 | 27.43% | 行业排名> |
| 2019-06-30 | 5.22% | 35.23% | 96.24% | 29/70 | 4.65% | 济川药业 | 23.05% | 行业排名> |
| 2019-03-31 | 2.66% | 19.82% | -60.82% | 34/70 | 2.89% | 济川药业 | 15.79% | 行业排名> |
| 2018-12-31 | 6.79% | -6.99% | -4.5% | 43/70 | 7.76% | 华润三九 | 10.23% | 行业排名> |
| 2018-09-30 | 7.11% | -8.14% | 84.2% | 37/70 | 7.93% | 济川药业 | 32.79% | 行业排名> |
| 2018-06-30 | 3.86% | -26.89% | 73.87% | 41/70 | 4.95% | 济川药业 | 27.55% | 行业排名> |
| 2018-03-31 | 2.22% | -15.27% | -69.59% | 39/70 | 2.72% | 济川药业 | 17.62% | 行业排名> |
| 2017-12-31 | 7.3% | -21.67% | -5.68% | 45/70 | 9.83% | 济川药业 | 10.07% | 行业排名> |
| 2017-09-30 | 7.74% | -20.7% | 46.59% | 37/70 | 8.33% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-06-30 | 5.28% | -20.72% | 101.53% | 32/70 | 5.2% | 济川药业 | 24.2% | 行业排名> |
| 2017-03-31 | 2.62% | 2.75% | -71.89% | 32/70 | 2.61% | *ST大药 | 15.31% | 行业排名> |
| 2016-12-31 | 9.32% | -52.52% | -4.51% | 36/70 | 10% | 济川药业 | 14.64% | 行业排名> |
| 2016-09-30 | 9.76% | -28.91% | 46.55% | 25/70 | 9.36% | 济川药业 | 7.64% | 行业排名> |
| 2016-06-30 | 6.66% | -31.48% | 161.18% | 25/70 | 5.05% | 维康药业 | 38.23% | 行业排名> |
| 2016-03-31 | 2.55% | -24.56% | -87.01% | 33/70 | 4.07% | 太极集团 | 58.41% | 行业排名> |
| 2015-12-31 | 19.63% | 44.44% | 42.97% | 10/70 | 11.33% | 新光药业 | 16.54% | 行业排名> |
| 2015-09-30 | 13.73% | 42.28% | 41.26% | 9/70 | 8.45% | 太极集团 | 71.6% | 行业排名> |
| 2015-06-30 | 9.72% | 40.06% | 187.57% | 9/70 | 5.5% | 维康药业 | 48.67% | 行业排名> |
| 2015-03-31 | 3.38% | 11.92% | -75.13% | 26/70 | 2.94% | 济川药业 | 21.37% | 行业排名> |